The incidence of endocarditis in the US is increasing, driven in part by the rise in
intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine) …

The global pandemic of COVID-19 is colliding with the epidemic of opioid use disorders
(OUD) and other substance use disorders (SUD) in the United States (US). Currently, there …

Abstract Background and Aims Individuals with opioid use disorder (OUD) suffer
disproportionately from COVID‐19. To inform clinical management of OUD patients …

The COVID-19 pandemic is a public health emergency. Individuals with substance use
disorder have a higher risk of infection and may suffer from more severe forms of the …

Introduction: Substance use disorder has been frequently reported to increase the risk of
infectious diseases, which might be owing to the sharing of contaminated inhalation …

Background Substance use disorders (SUD) elevate the risk for COVID-19 hospitalization,
but studies are inconsistent on the relationship of SUD to COVID-19 mortality. Methods …

abstract Background Alarms have been raised that COVID-19 may disproportionately affect
certain populations with substance use disorders, particularly Opioid Use Disorder (OUD) …

People with substance use disorder may be especially susceptible to COVID-19, and
compromised lung function from it could also put at risk those who have opioid use disorder …

Objective: While psychiatric disorders have been recognized as a risk factor for COVID-19
outcomes, the impact of substance use disorders (SUD) on COVID-19 outcomes has not, to …

Background Evidence suggests that individuals with history of substance use disorder
(SUD) are at increased risk of COVID-19, but little is known about relationships between …